-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Inflarx Provides Update On Phase 3 Data Analyses For Vilobelimab In Pyoderma Gangrenosum

路透·12/30/2025 13:33:10

登錄查看新聞詳情